REFERENCES
- Belfiore F, Iannello S, Volpicelli G. Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels. Mol Genet Metab 1998; 63: 134–141, [PUBMED], [INFOTRIEVE]
- Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22: 1462–1470, [PUBMED], [INFOTRIEVE]
- Garrow JS, Webster J. Quetelet’s index (W/H2) as a measure of fatness. Int J Obes 1991; 15: 295–302
- Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Matthews JN, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ 1990; 300: 230–235, [PUBMED], [INFOTRIEVE]
- Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Jose FC. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334: 292–295, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Dagogo-Jack S, Fanelli C, Paramore D, Brothers J, Landt M. Plasma leptin and insulin relationships in obese and nonobese humans. Diabetes 1996; 45: 695–698, [PUBMED], [INFOTRIEVE]
- Korbonits M, Trainer PJ, Little JA, Edwards R, Kopelman PG, Besser GM, Svec F, Grossman AB. Leptin levels do not change acutely with food administration in normal or obese subjects, but are negatively correlated with pituitary-adrenal activity. Clin Endocrinol (Oxf) 1997; 46: 751–757, [CROSSREF]
- Bougoulia M, Tzotzas T, Efthymiou H, Koliakos G, Konstantinidis T, Triantos A, Krassas GE. Leptin concentrations during oral glucose tolerance test (OGTT) in obese and normal weight women. Int J Obes Relat Metab Disord 1999; 23: 625–628, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Corica F, Corsonello A, Ientile R, De Gregorio T, Malara A, Artemisia A, Buemi M. Leptin and norepinephrine plasma concentrations during glucose loading in normotensive and hypertensive obese women. Am J Hypertens 2001; 14: 619–626, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Agata J, Masuda A, Takada M, Higashiura K, Murakami H, Miyazaki Y, Shimamoto K. High plasma immunoreactive leptin level in essential hypertension. Am J Hypertens 1997; 10: 1171–1174, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kazumi T, Kawaguchi A, Katoh J, Iwahashi M, Yoshino G. Fasting insulin and leptin serum levels are associated with systolic blood pressure independent of percentage body fat and body mass index. J Hypertens 1999; 17: 1451–1455, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Wauters M, Considine RV, Van Gaal LF. Human leptin: from an adipocyte hormone to an endocrine mediator. Eur J Endocrinol 2000; 143: 293–311, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Unger RH. Lipid overload and overflow: metabolic trauma and the metabolic syndrome. Trends Endocrinol Metab 2003; 19: 398–403, [CROSSREF]
- Oral EA, Simha V, Ruiz E, Andewelt A, Premkumar A, Snell P, Wagner AJ, DePaoli AM, Reitman ML, Taylor SI, Gorden P, Garg A. Leptin-replacement therapy for lipodystrophy. N Engl J Med 2002; 346: 570–578, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kakuma T, Lee Y, Higa M, Wang Z, Pan W, Shimomura I, Unger RH. Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets. Proc Natl Acad Sci 2000; 97: 8536–8541, [PUBMED], [INFOTRIEVE], [CROSSREF]
- World Health Organization. Diagnosis and Classification of Diabetes Mellitus, Definition, Diagnosis and Classification of Diabetes mellitus and its Complications, Part 1. World Health Organization. Department of Noncommunicable Disease Surveillance, Geneva 1999; 32–33
- Expert panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497, [CROSSREF]